Skystar Bio-Pharmaceutical Company Stock
Stocks
SKBI
US8308843007
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| Market Cap | 36.7M 32.67M 30.28M 27.44M 51.56M 3.48B 52.42M 363M 143M 1.82B 138M 135M 5.8B | P/E 2012 |
1.93x | P/E 2013 | 2.56x |
|---|---|---|---|---|---|
| Enterprise Value | 39.2M 34.89M 32.34M 29.3M 55.07M 3.71B 55.99M 388M 152M 1.94B 147M 144M 6.2B | EV / Sales 2012 |
0.2x | EV / Sales 2013 | 0.69x |
| Free-Float |
100% | Yield 2012 * |
-
| Yield 2013 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Tun Qu
BRD | Director/Board Member | 60 | 2008-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 0 | |
| +0.79% | -6.46% | +52.86% | +71.34% | 65.83B | |
| +1.92% | +10.35% | +13.02% | +87.74% | 51.87B | |
| +6.91% | +8.57% | +6.88% | +72.12% | 51.2B | |
| +0.79% | +3.00% | +26.63% | +45.64% | 43.76B | |
| +3.38% | +9.55% | +20.03% | +131.47% | 42.09B | |
| +7.54% | +4.08% | +263.12% | +601.18% | 39.04B | |
| -0.40% | +9.42% | +18.44% | +59.06% | 34B | |
| +3.84% | -4.94% | +42.35% | +8.92% | 25.2B | |
| +2.36% | +5.34% | +30.98% | +26.07% | 22.8B | |
| Average | +2.72% | +0.46% | +52.70% | +122.62% | 37.58B | |
| Weighted average by Cap. | +2.98% | +0.62% | +51.06% | +124.45% |
| 2012 | 2013 | |
|---|---|---|
| Net sales | 33.59M 29.9M 27.71M 25.11M 47.19M 3.18B 47.98M 332M 131M 1.67B 126M 123M 5.31B | 42.48M 37.81M 35.05M 31.76M 59.68M 4.02B 60.68M 421M 165M 2.11B 159M 156M 6.72B |
| Net income | 6.21M 5.53M 5.12M 4.64M 8.73M 589M 8.87M 61.49M 24.16M 308M 23.3M 22.82M 983M | 10.53M 9.37M 8.69M 7.87M 14.79M 998M 15.04M 104M 40.95M 522M 39.5M 38.68M 1.67B |
| Net Debt | -5.61M -4.99M -4.63M -4.19M -7.88M -531M -8.01M -55.52M -21.81M -278M -21.04M -20.6M -887M | 2.5M 2.22M 2.06M 1.87M 3.51M 237M 3.57M 24.73M 9.71M 124M 9.37M 9.18M 395M |
Employees
-
- Stock Market
- Stocks
- SKBI Stock
Select your edition
All financial news and data tailored to specific country editions
